Asia Pacific Protein Chip Market is segmented By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceuticals & Biotechnological Companies), and By Country (India, China, Japan, South Korea, and Rest of Asia Pacific) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Report Overview
The Asia Pacific Protein Chip Market is expected to grow at a CAGR of 18.6% during the forecast period 2023-2030.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
Asia Pacific Protein Chip Market Scope
|
Metrics |
Details |
|
CAGR |
18.6% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Technology, Application, and End User |
|
Countries Covered |
India, China, Japan, South Korea, and Rest of Asia Pacific |
|
Largest Country |
China |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Asia Pacific Protein Chip Market Dynamics
High Prevalence of Cancer and Growing Demand for Personalized Medicine
The growing desire for customized treatment, the high frequency of cancer, rising R&D investment, and the availability of technical breakthroughs in the area are all factors driving the Asia-Pacific protein chip market. The development of new protein chips in Asian countries is expected to open new opportunities for market players in the future. A growing pace of research in India has fuelled demand for biochips, contributing to the market's overall development. Due to multiple startups and improvements in lab-on-a-chip technology, as well as the region's desire for bespoke diagnostic solutions, the usage of microarray chips in viral testing in Indian cattle has quickly grown.
Many APAC locations have a high cancer incidence, which has raised the demand for specialized diagnostic solutions based on protein chips. According to the WHO, cancer killed approximately 4.5 million people in 2016, accounting for 16.0% of all deaths in the Asia-Pacific area. As a result, the growing focus on clinical research, technical advancements, precision medicine, and new medication discovery is propelling the APAC protein chip market forward.
Asia Pacific Protein Chip Market Segmentation
The Asia Pacific Protein Chip Market can be segmented by technology, application, and end user.
The hospitals and clinics segment is expected to have the leading share of this market over the projection period. This forecast is due to the rising incidence of infectious diseases, cancer events, and post-surgical complications.
Among all, research institutions proved to be the fastest growing. This is owing to their critical significance in the advancement of proteome studies. These institutions serve as centres for cutting-edge scientific research, and they are increasingly using protein chip technology to speed up protein profiling, interaction studies, and disease biomarker discoveries. The need for protein chips is being driven by the need for a thorough knowledge of protein activities and their consequences in illnesses.
Regional Insights
By region, the Asia Pacific protein chip market is segmented into India, China, Japan, South Korea, and the Rest of Asia Pacific.
The Chinese regional market is expected to develop at the fastest CAGR during the forecast period due to increased investment by government and non-government organizations in the area to improve health infrastructure. According to the World Bank, health spending as a proportion of GDP in China increased to 5.3% in 2018 from 4.2% in 2010. The region's high cancer incidence and huge senior population would benefit the industry under consideration. Breast cancer incidence in Singapore declined from 20 per 100,000 per year in 1972 to 60 per 100,000 between 2006 and 2010, according to a survey published in the Critical Illness Journal. While incidence rates in China and India have climbed by up to 30% over the last few decades, rates in Japan, Korea, and Singapore have quadrupled or even tripled in recent years.
Key Players Operating in the Asia Pacific Protein Chip Market
- SEQUENOM, Inc.
- Sigma Aldrich Corporation
- Affymetrix, Inc.
- EMD Millipore
- Illumina, Inc.
- Life Technologies Corporation
- Agilent Technologies.
